메뉴 건너뛰기




Volumn 257, Issue 4, 2010, Pages 540-545

Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease

Author keywords

Brain derived neurotrophic factor; Depression; Motor impairment; Neurodegeneration; Neurotrophins; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LEVODOPA;

EID: 77951255298     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5357-2     Document Type: Article
Times cited : (238)

References (31)
  • 1
    • 18844417688 scopus 로고    scopus 로고
    • A definition of Parkinson's disease
    • DOI 10.1016/j.parkreldis.2005.01.008, PII S1353802005000404
    • D Calne 2005 A definition of Parkinson's disease Parkinsonism Relat Disord 11 S39 S40 10.1016/j.parkreldis.2005.01.008 15885627 (Pubitemid 40693576)
    • (2005) Parkinsonism and Related Disorders , vol.11 , Issue.SUPPL. 1
    • Calne, D.1
  • 2
    • 5744233877 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor
    • DOI 10.1080/08977190410001723308
    • DK Binder HE Scharfman 2004 Brain-derived neurotrophic factor Growth Factors 22 123 131 10.1080/08977190410001723308 1:CAS:528:DC%2BD2cXpt1alu7c%3D 15518235 (Pubitemid 39377904)
    • (2004) Growth Factors , vol.22 , Issue.3 , pp. 123-131
    • Binder, D.K.1    Scharfman, H.E.2
  • 3
    • 37849050242 scopus 로고    scopus 로고
    • Neurotrophic factors in Alzheimer's disease: Role of axonal transport
    • 1:CAS:528:DC%2BD1cXivVyhsrs%3D 18184369
    • K Schindowski K Belarbi L Buée 2008 Neurotrophic factors in Alzheimer's disease: role of axonal transport Genes Brain Behav 7 43 56 1:CAS:528:DC%2BD1cXivVyhsrs%3D 18184369
    • (2008) Genes Brain Behav , vol.7 , pp. 43-56
    • Schindowski, K.1    Belarbi, K.2    Buée, L.3
  • 5
    • 0033762265 scopus 로고    scopus 로고
    • Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra
    • 10.1006/exnr.2000.7483 1:CAS:528:DC%2BD3cXnt1WjsLk%3D 11031089
    • DW Howells MJ Porritt JYF Wong, et al. 2000 Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra Exp Neurol 166 127 135 10.1006/exnr.2000.7483 1:CAS:528:DC%2BD3cXnt1WjsLk%3D 11031089
    • (2000) Exp Neurol , vol.166 , pp. 127-135
    • Howells, D.W.1    Porritt, M.J.2    Wong, J.Y.F.3
  • 6
    • 0033602009 scopus 로고    scopus 로고
    • Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
    • K Parain MG Murer Y Quiao, et al. 1999 Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra Neuroreport 10 557 561 10.1097/00001756-199902250-00021 1:STN:280:DyaK1M3itlarug%3D%3D 10208589 (Pubitemid 29333282)
    • (1999) NeuroReport , vol.10 , Issue.3 , pp. 557-561
    • Parain, K.1    Murer, M.G.2    Yan, Q.3    Faucheux, B.4    Agid, Y.5    Hirsch, E.6    Raisman-Vozari, R.7
  • 7
    • 0033597983 scopus 로고    scopus 로고
    • Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease
    • DOI 10.1016/S0304-3940(99)00463-2, PII S0304394099004632
    • M Mogi A Togaria T Kondo, et al. 1999 Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease Neurosci Lett 270 45 48 10.1016/S0304-3940(99)00463-2 1:CAS:528:DyaK1MXksFait74%3D 10454142 (Pubitemid 29322994)
    • (1999) Neuroscience Letters , vol.270 , Issue.1 , pp. 45-48
    • Mogi, M.1    Togari, A.2    Kondo, T.3    Mizuno, Y.4    Komure, O.5    Kuno, S.6    Ichinose, H.7    Nagatsu, T.8
  • 8
    • 0036092437 scopus 로고    scopus 로고
    • Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra
    • DOI 10.1016/S1353-8020(02)00008-1, PII S1353802002000081
    • C Knott G Stern A Kingsbury 2002 Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra Parkinsonism Relat Disord 8 329 341 10.1016/S1353-8020(02)00008-1 1:STN:280:DC%2BD2c3nvFemsw%3D%3D 15177062 (Pubitemid 34518414)
    • (2002) Parkinsonism and Related Disorders , vol.8 , Issue.5 , pp. 329-341
    • Knott, C.1    Stern, G.2    Kingsbury, A.3    Welcher, A.A.4    Wilkin, G.P.5
  • 9
    • 27944457221 scopus 로고    scopus 로고
    • The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: A meta-analysis
    • DOI 10.1007/s10038-005-0295-z
    • E Zintzaras GM Hadjigeorgiou 2005 The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis J Hum Genet 50 560 566 10.1007/s10038-005-0295-z 1:CAS:528:DC%2BD2MXht1enu7zF 16172806 (Pubitemid 41666975)
    • (2005) Journal of Human Genetics , vol.50 , Issue.11 , pp. 560-566
    • Zintzaras, E.1    Hadjigeorgiou, G.M.2
  • 10
    • 0029610630 scopus 로고
    • Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease
    • M Levivier S Przedborski C Bencsics UJ Kang 1995 lntrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease J Neurosci 15 7810 7820 1:CAS:528:DyaK28Xls1Cl 8613721 (Pubitemid 26006890)
    • (1995) Journal of Neuroscience , vol.15 , Issue.12 , pp. 7810-7820
    • Levivier, M.1    Przedborski, S.2    Bencsics, C.3    Kang, U.J.4
  • 11
    • 38449122713 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons
    • 10.1007/BF03033922 1:CAS:528:DC%2BD2sXhtlKiu7fO 17967737
    • I Mocchetti A Bachis RL Nosheny G Tanda 2007 Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons Neurotox Res 12 135 143 10.1007/BF03033922 1:CAS:528:DC%2BD2sXhtlKiu7fO 17967737
    • (2007) Neurotox Res , vol.12 , pp. 135-143
    • Mocchetti, I.1    Bachis, A.2    Nosheny, R.L.3    Tanda, G.4
  • 12
    • 34248215035 scopus 로고    scopus 로고
    • Measurements of brain-derived neurotrophic factor: Methodological aspects and demographical data
    • DOI 10.1016/j.brainresbull.2007.03.009, PII S0361923007001049
    • V Trajkovska AB Marcussen M Vinberg, et al. 2007 Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data Brain Res Bull 73 143 149 10.1016/j.brainresbull.2007.03.009 1:CAS:528:DC%2BD2sXlt1aju7s%3D 17499648 (Pubitemid 46722657)
    • (2007) Brain Research Bulletin , vol.73 , Issue.1-3 , pp. 143-149
    • Trajkovska, V.1    Marcussen, A.B.2    Vinberg, M.3    Hartvig, P.4    Aznar, S.5    Knudsen, G.M.6
  • 15
    • 45849098660 scopus 로고    scopus 로고
    • The accuracy of diagnosis of major depression in patients with Parkinson's disease: A comparative study among the UPDRS, the geriatric depression scale and the Beck Depression Inventory
    • DOI 10.1590/S0004-282X2008000200002
    • V Tumas GGR Rodrigues TLA Farias JAS Crippa 2008 The accuracy of diagnosis of major depression in patients with Parkinson's disease: A comparative study among the UPDRS, the Geriatric Depression Scale and the Beck Depression Inventory Arq Neuropsiquiatr 66 152 156 18545773 (Pubitemid 351883892)
    • (2008) Arquivos de Neuro-Psiquiatria , vol.66 , Issue.A2 , pp. 152-156
    • Tumas, V.1    Rodrigues, G.G.R.2    Farias, T.L.A.3    Crippa, J.A.S.4
  • 16
    • 0000224448 scopus 로고
    • Unified Parkinson's disease rating scale
    • Fahn S, Marsden CD, Caine DB, Goldstein M, (eds) Macmillan Health Care information, Florham Park 293-304
    • Fahn S, Elton R (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Caine DB, Goldstein M, (eds) Recent developments in Parkinson's disease, vol 2. Macmillan Health Care information, Florham Park, pp 153-163, 293-304
    • (1987) Recent Developments in Parkinson's Disease , vol.2 , pp. 153-163
    • Fahn, S.1    Elton, R.2
  • 17
    • 0014082977 scopus 로고
    • Parkinsonism: Onset, progression and mortality
    • 1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
    • MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
    • (1967) Neurology , vol.17 , pp. 427-442
    • Hoehn, M.M.1    Yahr, M.D.2
  • 19
    • 0026031194 scopus 로고
    • The timed "up and Go": A test of basic functional mobility for frail elderly persons
    • 1:STN:280:DyaK3M7itlKgsA%3D%3D 1991946
    • D Podsiadlo S Richardson 1991 The timed "Up and Go": a test of basic functional mobility for frail elderly persons J Am Geriatr Soc 39 142 148 1:STN:280:DyaK3M7itlKgsA%3D%3D 1991946
    • (1991) J Am Geriatr Soc , vol.39 , pp. 142-148
    • Podsiadlo, D.1    Richardson, S.2
  • 20
    • 0036255090 scopus 로고    scopus 로고
    • Reliability of gait speed measured by a timed walking test in patients one year after stroke
    • DOI 10.1191/0269215502cr495oa
    • J Green A Forster J Young 2002 Reliability of gait speed measured by a timed walking test in patients one year after stroke Clin Rehabil 16 306 314 10.1191/0269215502cr495oa 12017517 (Pubitemid 34467222)
    • (2002) Clinical Rehabilitation , vol.16 , Issue.3 , pp. 306-314
    • Green, J.1    Forster, A.2    Young, J.3
  • 21
    • 0036644465 scopus 로고    scopus 로고
    • ATS statement: Guidelines for the six minute walk test
    • ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
    • ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories 2002 ATS statement: guidelines for the six minute walk test Am J Resp Crit Care Med 166 111 117
    • (2002) Am J Resp Crit Care Med , vol.166 , pp. 111-117
  • 22
    • 21544446985 scopus 로고    scopus 로고
    • Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta
    • DOI 10.1523/JNEUROSCI.4601-04.2005
    • ZC Baquet PC Bickford KR Jones 2005 Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta J Neurosci 25 6251 6259 10.1523/JNEUROSCI. 4601-04.2005 1:CAS:528:DC%2BD2MXmtFKntb4%3D 15987955 (Pubitemid 40923492)
    • (2005) Journal of Neuroscience , vol.25 , Issue.26 , pp. 6251-6259
    • Baquet, Z.C.1    Bickford, P.C.2    Jones, K.R.3
  • 23
    • 13444273332 scopus 로고    scopus 로고
    • Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons
    • DOI 10.1016/j.expneurol.2004.11.030
    • MJ Porritt PE Batchelor DW Howells 2005 Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons Exp Neurol 192 226 234 10.1016/j.expneurol.2004.11.030 1:CAS:528: DC%2BD2MXhtVKgs7s%3D 15698637 (Pubitemid 40208556)
    • (2005) Experimental Neurology , vol.192 , Issue.1 , pp. 226-234
    • Porritt, M.J.1    Batchelor, P.E.2    Howells, D.W.3
  • 24
    • 33750049661 scopus 로고    scopus 로고
    • Serum BDNF, TNF-α and IL-1β levels in dementia patients: Comparison between Alzheimer's disease and vascular dementia
    • DOI 10.1007/s00406-006-0652-8
    • C Yasutake K Kuroda T Yanagawa, et al. 2006 Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia Eur Arch Psychiatry Clin Neurosci 256 402 406 10.1007/s00406-006-0652-8 16783499 (Pubitemid 44584054)
    • (2006) European Archives of Psychiatry and Clinical Neuroscience , vol.256 , Issue.7 , pp. 402-406
    • Yasutake, C.1    Kuroda, K.2    Yanagawa, T.3    Okamura, T.4    Yoneda, H.5
  • 26
    • 34248663802 scopus 로고    scopus 로고
    • Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder
    • DOI 10.1016/j.neulet.2007.04.001, PII S0304394007004004
    • CS Gama AC Andreazza M Kunz, et al. 2007 Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder Neurosci Lett 420 45 48 10.1016/j.neulet.2007.04.001 1:CAS:528:DC%2BD2sXlvVyiurY%3D 17442489 (Pubitemid 46777098)
    • (2007) Neuroscience Letters , vol.420 , Issue.1 , pp. 45-48
    • Gama, C.S.1    Andreazza, A.C.2    Kunz, M.3    Berk, M.4    Belmonte-de-Abreu, P.S.5    Kapczinski, F.6
  • 27
    • 44649183920 scopus 로고    scopus 로고
    • Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia
    • 10.1016/j.neulet.2008.05.022 1:CAS:528:DC%2BD1cXmvVKks7w%3D 18514407
    • HJ Reis R Nicolato IG Barbosa, et al. 2008 Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia Neurosci Lett 439 157 159 10.1016/j.neulet.2008.05.022 1:CAS:528:DC%2BD1cXmvVKks7w%3D 18514407
    • (2008) Neurosci Lett , vol.439 , pp. 157-159
    • Reis, H.J.1    Nicolato, R.2    Barbosa, I.G.3
  • 28
    • 33847254358 scopus 로고    scopus 로고
    • Brain derived neurotropic factor in first-episode psychosis
    • DOI 10.1016/j.schres.2006.12.026, PII S0920996407000357
    • PF Buckley A Pillai D Evans, et al. 2007 Brain derived neurotropic factor in first-episode psychosis Schizophr Res 91 1 5 10.1016/j.schres.2006.12.026 17306505 (Pubitemid 46320904) (Pubitemid 46320904)
    • (2007) Schizophrenia Research , vol.91 , Issue.1-3 , pp. 1-5
    • Buckley, P.F.1    Pillai, A.2    Evans, D.3    Stirewalt, E.4    Mahadik, S.5
  • 29
    • 0025515348 scopus 로고
    • The relationship of negative schizophrenia to parkinsonism
    • 10.3109/00207459008987178 1:STN:280:DyaK3M%2FnvV2hug%3D%3D 2147920
    • R Sandyk SR Kay 1990 The relationship of negative schizophrenia to parkinsonism Int J Neurosci 55 1 59 10.3109/00207459008987178 1:STN:280:DyaK3M%2FnvV2hug%3D%3D 2147920
    • (1990) Int J Neurosci , vol.55 , pp. 1-59
    • Sandyk, R.1    Kay, S.R.2
  • 30
    • 0028856570 scopus 로고
    • Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients
    • 1:STN:280:DyaK28%2FotVSjtA%3D%3D 8526237
    • A Chatterjee M Chakos A Koreen, et al. 1995 Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients Am J Psychiatry 152 1724 1729 1:STN:280: DyaK28%2FotVSjtA%3D%3D 8526237
    • (1995) Am J Psychiatry , vol.152 , pp. 1724-1729
    • Chatterjee, A.1    Chakos, M.2    Koreen, A.3
  • 31
    • 34248570313 scopus 로고    scopus 로고
    • Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease
    • T Yasuhara T Shingo I Date 2007 Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease Acta Med Okayama 61 51 56 1:CAS:528:DC%2BD2sXlsVSltb8%3D 17471304 (Pubitemid 46798852)
    • (2007) Acta Medica Okayama , vol.61 , Issue.2 , pp. 51-56
    • Yasuhara, T.1    Shingo, T.2    Date, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.